Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (511-520 of 13,981) with videos related to

Pageof 1,399
Sort By:
Leukemia|March 10, 2001
Comparison of methods for assessment of minimal residual disease in childhood B-lineage acute lymphoblastic leukemiaM J Brisco, P J Sykes, E Hughes, et al.
Leukemia|March 10, 2001
The role of AP-1 in glucocorticoid resistance in leukaemiaS Bailey, A G Hall, A D Pearson, et al.
Leukemia|March 10, 2001
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssionM D Tabernero, A M Bortoluci, I Alaejos, et al.
Leukemia|December 16, 2022
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemiaKailong Jiang, Xuemei Li, Chang Wang, et al.
Leukemia|December 16, 2022
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencingJanine Müller, Wencke Walter, Claudia Haferlach, et al.
Leukemia|July 18, 2023
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary diseaseOla Rizq, Naoya Mimura, Motohiko Oshima, et al.
Leukemia|July 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Leukemia|June 21, 2024
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cellsNicolas Chatain, Julian Baumeister, Marcelo A Szymanski de Toledo, et al.
Pageof 1,399

Showing results (511-520 of 13,981) with videos related to

Sort By:
Pageof 1,399
Leukemia|March 10, 2001
Comparison of methods for assessment of minimal residual disease in childhood B-lineage acute lymphoblastic leukemiaM J Brisco, P J Sykes, E Hughes, et al.
Leukemia|March 10, 2001
The role of AP-1 in glucocorticoid resistance in leukaemiaS Bailey, A G Hall, A D Pearson, et al.
Leukemia|March 10, 2001
Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssionM D Tabernero, A M Bortoluci, I Alaejos, et al.
Leukemia|December 16, 2022
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemiaKailong Jiang, Xuemei Li, Chang Wang, et al.
Leukemia|December 16, 2022
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencingJanine Müller, Wencke Walter, Claudia Haferlach, et al.
Leukemia|July 18, 2023
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary diseaseOla Rizq, Naoya Mimura, Motohiko Oshima, et al.
Leukemia|July 19, 2023
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Leukemia|May 25, 2024
TP53 mutation screening for patients at risk of myeloid malignancyDevdeep Mukherjee, Rialnat A Lawal, Courtney D Fitzhugh, et al.
Leukemia|June 21, 2024
Asciminib antagonizes transplantable BCR::ABL1-positive lymphoid blast crisis in vivo by targeting malignant stem cellsNicolas Chatain, Julian Baumeister, Marcelo A Szymanski de Toledo, et al.
Pageof 1,399